To : Annelies Bon Re : Moclobemide Moclobemide is an atypical MAO inhibitor that still has moderate drug-drug interactions as with the typical MAO inhibitors. It is not marketed in the US probably because this family of antidepressants is so unpopular with physicians. In one study of 6 women 0.06% of a single maternal dose was excreted into human milk within a 24 hour period. I still would suggest that Zoloft or Paxil would be less hazardous for a breastfeeding pair. Regards Tom Hale, Ph.D.